In hematologic malignancies, vitamin C treatment might enhance the enzymatic activity of TET2 to promote 5hmC formation and DNA demethylation in myelodysplastic syndrome or acute myeloid leukemia cells [35]. This evidence concerns the gene TET2 and hematologic disorder.